BeOne Medicines Ltd.
ONCNasdaqCIK 1651308HealthcareFiscal year ends Dec 31
Reports and events: 376 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-09-3006:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000123 |
| 2024-09-2606:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001651308-24-000118 |
| 2024-08-2907:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001651308-24-000110 |
| 2024-08-0706:07 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001651308-24-000098 |
| 2024-08-0706:04 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000097 |
| 2024-07-1806:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001651308-24-000086 |
| 2024-06-0516:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001651308-24-000055 |
| 2024-05-0806:09 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001651308-24-000051 |
| 2024-05-0806:06 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000049 |
| 2024-04-2616:16 ET | DEF 14A | Proxy statementPeriod 2024-06-05 | 0001104659-24-052961 |
| 2024-04-2607:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001651308-24-000043 |
| 2024-04-2316:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000039 |
| 2024-03-2016:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000032 |
| 2024-03-1516:52 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000028 |
| 2024-03-0806:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000021 |
| 2024-02-2606:16 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001651308-24-000014 |
| 2024-02-2606:02 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000011 |
| 2024-01-2306:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001651308-24-000005 |
| 2023-12-0806:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-23-000170 |
| 2023-11-1417:18 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-118243 |
| 2023-11-0916:14 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001651308-23-000165 |
| 2023-11-0916:08 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-23-000163 |
| 2023-10-2016:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-23-000152 |
| 2023-09-2116:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-23-000141 |
| 2023-09-1906:01 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001651308-23-000137 |
| 2023-08-2916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001651308-23-000134 |
| 2023-08-0206:23 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001651308-23-000127 |
| 2023-08-0206:13 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-23-000125 |
| 2023-07-2416:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-23-000115 |
| 2023-07-1106:01 ET | 8-K | 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-23-000107 |
| 2023-06-1516:43 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-23-000085 |
| 2023-05-2616:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-23-000077 |
| 2023-05-0816:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-23-000072 |
| 2023-05-0516:33 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-056587 |
| 2023-05-0407:17 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001651308-23-000068 |
| 2023-05-0407:07 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-23-000066 |
| 2023-04-2716:38 ET | DEF 14A | Proxy statement | 0001104659-23-051427 |
| 2023-04-2516:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001651308-23-000061 |
| 2023-04-2016:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-23-000056 |
| 2023-03-2916:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-23-000044 |
| 2023-02-2707:35 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001651308-23-000036 |
| 2023-02-2707:07 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-23-000031 |
| 2023-02-1416:14 ET | SC 13D/A | Ownership report, active investor, amended | 0000902664-23-001816 |
| 2023-01-3116:26 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001651308-23-000025 |
| 2023-01-2316:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-23-000022 |
| 2023-01-0516:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-23-000005 |
| 2022-12-1916:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-22-000235 |
| 2022-11-2216:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-22-000224 |
| 2022-11-0907:12 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001651308-22-000209 |
| 2022-11-0907:06 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-22-000208 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:09 ET. Listed shows no prices and gives no investment advice.